Mérieux Equity Partners

Mérieux Equity Partners is a prominent European private equity firm specializing in the healthcare sector. Established in 2009, the firm manages over €1.5 billion in assets and operates through two dedicated platforms: Innovation and Buyout. These platforms support companies ranging from startups to established leaders, focusing on investments that offer transformative products or services in healthcare. The firm is AMF-registered and has offices in Paris and Lyon. The Innovation platform targets early-stage companies, investing between €3 million and €15 million in minority stakes across Europe. It focuses on disruptive technologies in diagnostics, therapeutics, and pharma services, supporting entrepreneurs from seed to Series B stages. The Buyout platform invests in profitable and fast-growing companies, committing between €20 million and €80 million in majority or minority stakes. It covers the entire healthcare sector, including pharmaceuticals, medtech, life science tools, and preventive medicine, supporting both organic growth and M&A strategies. Mérieux Equity Partners is known for its active partnership with management teams, providing not only capital but also strategic support leveraging its extensive sector expertise and international network. The firm has a solid track record, having completed over 50 investments since its inception, and continues to demonstrate its commitment to fostering innovation and growth in the healthcare industry.